- Home
- IMRN vs MTNB Comparison
IMRN vs MTNB Comparison
Compare IMRN & MTNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMRN
- MTNB
- Stock Information
- Founded
- IMRN 1994
- MTNB 2013
- Country
- IMRN Australia
- MTNB United States
- Employees
- IMRN N/A
- MTNB N/A
- Industry
- IMRN Biotechnology: Pharmaceutical Preparations
- MTNB Biotechnology: Pharmaceutical Preparations
- Sector
- IMRN Health Care
- MTNB Health Care
- Exchange
- IMRN Nasdaq
- MTNB Nasdaq
- Market Cap
- IMRN 9.2M
- MTNB 9.7M
- IPO Year
- IMRN N/A
- MTNB N/A
- Fundamental
- Price
- IMRN $1.80
- MTNB $1.66
- Analyst Decision
- IMRN Strong Buy
- MTNB Hold
- Analyst Count
- IMRN 1
- MTNB 1
- Target Price
- IMRN $5.00
- MTNB N/A
- AVG Volume (30 Days)
- IMRN 46.0K
- MTNB 87.7K
- Earning Date
- IMRN 08-29-2025
- MTNB 11-12-2025
- Dividend Yield
- IMRN N/A
- MTNB N/A
- EPS Growth
- IMRN N/A
- MTNB N/A
- EPS
- IMRN N/A
- MTNB N/A
- Revenue
- IMRN $4,777,422.00
- MTNB N/A
- Revenue This Year
- IMRN N/A
- MTNB N/A
- Revenue Next Year
- IMRN N/A
- MTNB N/A
- P/E Ratio
- IMRN N/A
- MTNB N/A
- Revenue Growth
- IMRN 48.63
- MTNB N/A
- 52 Week Low
- IMRN $1.50
- MTNB $0.47
- 52 Week High
- IMRN $2.87
- MTNB $4.25
- Technical
- Relative Strength Index (RSI)
- IMRN 48.13
- MTNB 49.91
- Support Level
- IMRN $1.80
- MTNB $1.65
- Resistance Level
- IMRN $1.94
- MTNB $1.88
- Average True Range (ATR)
- IMRN 0.08
- MTNB 0.13
- MACD
- IMRN -0.01
- MTNB -0.05
- Stochastic Oscillator
- IMRN 22.22
- MTNB 15.22
About IMRN Immuron Limited
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.
About MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.